Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
3
100%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (100.0%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_2

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

NCT06084338
completedphase_2

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

NCT01270841
completedphase_2

HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

NCT00183040

Clinical Trials (3)

Showing 3 of 3 trials
NCT06084338Phase 2

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

Recruiting
NCT01270841Phase 2

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

Completed
NCT00183040Phase 2

HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3